Biodexa Pharmaceuticals (BDRX) Return on Equity [ROE] (2016 - 2026)
Biodexa Pharmaceuticals (BDRX) recorded Return on Equity [ROE] of -126.26% in the quarter ended Jun 30, 2026, up 20.79 percentage points from -147.05% a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Biodexa Pharmaceuticals reported Return on Equity [ROE] of -65.57%, up 23.43 percentage points from the prior year.
- Annual Return on Equity [ROE] has a five-year change of +104.04 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, Return on Equity [ROE] came in at -89.00% in the year ended Dec 31, 2024 (+91.95 pp), -180.95% in the year ended Dec 31, 2023 (-77.36 pp), -103.59% in the year ended Dec 31, 2022 (-38.28 pp) and -65.30% in the year ended Dec 31, 2021 (+104.31 pp).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Return on Equity [ROE] since the quarter ended Dec 31, 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Biodexa Pharmaceuticals | 39.17 Mn | 15.95 Mn | - | -126.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -126.26% |
| Dec 31, 2025 | -132.72% |
| Jun 30, 2025 | -147.05% |
| Dec 31, 2024 | -194.80% |
| Jun 30, 2023 | -887.17% |
| Dec 31, 2022 | -821.88% |
| Dec 31, 2021 | -713.43% |
| Dec 31, 2020 | -934.03% |
| Dec 31, 2019 | -200.69% |
| Dec 31, 2018 | -255.84% |
| Dec 31, 2017 | -135.86% |
| Dec 31, 2016 | -112.61% |
API Access
Biodexa Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();